VCEL Shares Outstanding History



Below is a table of the VCEL shares outstanding history going back to 10/16/2013:

Date VCEL Shares Outstanding
10/16/20130.00B
10/31/20134.38M
2/28/20146.16M
4/30/20146.50M
7/31/20148.00M
10/31/201423.79M
11/24/201423.79M
3/19/201523.79M
5/8/201523.79M
8/6/201523.79M
11/6/201523.79M
3/8/201623.85M
5/3/201623.93M
8/5/201624.00M
11/4/201624.11M
3/10/201732.72M
5/4/201732.77M
8/7/201732.82M
11/3/201734.91M
2/28/201836.10M
5/4/201836.68M
8/3/201842.73M
11/2/201843.35M
2/22/201943.75M
5/3/201943.91M
7/31/201944.14M
6/15/201828.98M
10/31/201944.69M
2/21/202044.95M
4/30/202045.11M
7/31/202045.25M
10/30/202045.43M
2/15/202145.95M
4/30/202146.36M
7/30/202146.63M
10/29/202146.82M
2/18/202246.97M
4/29/202247.12M
7/29/202247.18M
11/4/202247.22M
2/17/202347.36M
4/30/202347.56M
7/27/202347.64M
11/2/202347.72M
2/21/202448.29M

Also see: VCEL Market Cap History
VCEL YTD Return
VCEL Historical Shares Outstanding:
+34.27% CAGR
VCEL Historical Shares Outstanding: +34.27% CAGR

Mouse over chart for data details
10/16/2013 ...2/21/2024
Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns. We show 45 historical shares outstanding datapoints in our coverage of VCEL's shares outstanding history.

Understanding the changing numbers of VCEL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VCEL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VCEL by allowing them to research VCEL shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VCEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vericel (VCEL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VCNX Shares Outstanding History
VCYT Shares Outstanding History
VERA Shares Outstanding History
VERO Shares Outstanding History
VERU Shares Outstanding History
VERV Shares Outstanding History
VICL Shares Outstanding History
VIE Shares Outstanding History
VIGL Shares Outstanding History
VINC Shares Outstanding History
More Healthcare companies »

 

VCEL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.